Overview
Background
Matthew J. Roberts, BSc, MBBS, PhD, FRACS (Urol)
- Consultant Urologist, Royal Brisbane and Women’s (RBWH), Surgical Treatment and Rehabilitation Service (STARS), Queensland Health
- Clinician Research Fellow, Metro North Hospital and Health Service
- Group Leader & Associate Professor, The University of Queensland Centre for Clinical Research
Matthew is a medical graduate of The University of Queensland and completed Urology specialty training in Queensland and New South Wales. He completed his PhD under the supervision of Professor “Frank” Gardiner investigating new biomarkers for the early detection and characterization of prostate cancer.
Matthew is a surgeon-scientist, working clinically as a urologist and robotic surgeon at RBWH & STARS with academic appointment as Clinician Research Fellow at Metro North Health (Qld) and Associate Professor at UQCCR. His clinical and research interests are in Urologic cancers (e.g. prostate cancer), focusing on novel imaging and biomarkers, clinical trials, urological infections and innovation in urology. He has authored over 140 peer reviewed manuscripts in international journals and presented research at more than 20 international urology and clinical cancer meetings. He is a member of the EAU Prostate Cancer Guidelines Committee, Prostate Cancer Outcomes Registry (PCOR)-Queensland Steering Committee, Editorial Board of the BJU International, as well as Co-Convenor of the ANZUP 2024 ASM.
Availability
- Dr Matthew Roberts is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Biomedical Science, The University of Queensland
- Bachelor of Medicine, The University of Queensland
- Doctor of Philosophy, The University of Queensland
Research interests
-
Urology
All fields related to urology including urologic oncology, prostate cancer, kidney/renal cancer, bladder cancer and others. Urologic infections Quality-of-life and survivorship research Systematic review and meta-analysis.
Works
Search Professor Matthew Roberts’s works on UQ eSpace
2024
Journal Article
The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer related pathology: A single centre retrospective study
Franklin, Anthony, Gianduzzo, Troy, Kua, Boon, Wong, David, McEwan, Louise, Walters, James, Esler, Rachel, Roberts, Matthew J., Coughlin, Geoff and Yaxley, John W. (2024). The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer related pathology: A single centre retrospective study. Asian Journal of Urology, 11 (1), 33-41. doi: 10.1016/j.ajur.2023.01.007
2024
Journal Article
Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories
Aziz, Moez Karim, Molony, Donald, Monlezun, Dominique, Holder, Travis, Brunckhorst, Oliver, Higgason, Noel, Roland, Jerry, Magill, Resa, Fatakdawala, Mariya, Iacobucci, Alexander, Mody-Bailey, Neal, Owen, Chris, Zarker, Andrew, Thames, Emma, Swaby, Justin, Xiao, Daniel, Choi, Lily, Desai, Shubh, Galan, Jacob, Deng, Brett, Hartshorne, Taylor, Nichols, Alexis, Zhang, Allan, Imber, Jared, Song, Jeffrey, Jones, William, Rivas, Alexis, Sanchez, Darren, Guhan, Maya ... Canfield, Steven (2024). Prostate Cancer Therapy Cardiotoxicity Map (PROXMAP) for Advanced Disease States: A Systematic Review and Network Meta-analysis with Bayesian Modeling of Treatment Histories. European Urology, 87 (1), 15-26. doi: 10.1016/j.eururo.2024.08.031
2023
Journal Article
Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography
Vis, André N., Meijer, Dennie, Roberts, Matthew J., Siriwardana, Amila R., Morton, Andrew, Yaxley, John W., Samaratunga, Hemamali, Emmett, Louise, van de Ven, Peter M., Heymans, Martijn W., Nieuwenhuijzen, Jakko A., van der Poel, Henk G., Donswijk, Maarten L., Boellaard, Thierry N., Schoots, Ivo G., Stricker, Phillip, Haynes, Anne-Maree, Oprea-Lager, Daniela E., Coughlin, Geoffrey D. and van Leeuwen, Pim J. (2023). Development and external validation of a novel nomogram to predict the probability of pelvic lymph-node metastases in prostate cancer patients using magnetic resonance imaging and molecular imaging with prostate-specific membrane antigen positron emission tomography. European Urology Oncology, 6 (6), 553-563. doi: 10.1016/j.euo.2023.03.010
2023
Journal Article
The effectiveness of a criteria-led discharge initiative on the length of stay of patients who underwent a robotic-assisted laparoscopic prostatectomy
Saad, Jeremy, Shanmugasundaram, Ramesh, Canagasingham, Bertram, Ferguson, Richard, Goolam, Ahmed, Khadra, Mohamed, Ko, Raymod, McCombie, Steve P., Reddy, Sumeet, Roberts, Matthew J., Thangasamy, Isaac, Varol, Celi, Zhong, Wenjie and Arianayagam, Mohan (2023). The effectiveness of a criteria-led discharge initiative on the length of stay of patients who underwent a robotic-assisted laparoscopic prostatectomy. Société Internationale d’Urologie Journal, 4 (6), 458-463. doi: 10.48083/plly8153
2023
Conference Publication
Quality of health information in ChatGPT responses to common patient enquiries about recurrent UTI treatment and prevention
Collin, Harry and Roberts, Matthew (2023). Quality of health information in ChatGPT responses to common patient enquiries about recurrent UTI treatment and prevention. Annual Scientific Meeting of the Singapore-Urological-Association (SUA), Singapore, 6-8 July 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.
2023
Conference Publication
Virtual healthcare delivery in urology - is AI the future for patient information on prostate cancer?
Collin, Harry and Roberts, Matthew (2023). Virtual healthcare delivery in urology - is AI the future for patient information on prostate cancer?. Annual Scientific Meeting of the Singapore-Urological-Association (SUA), Singapore, 6-8 July 2023. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.
2023
Journal Article
68Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study
Gondoputro, William, Doan, Paul, Katelaris, Athos, Scheltema, Matthijs J., Geboers, Bart, Agrawal, Shikha, Liu, Zhixin, Yaxley, John, Savdie, Richard, Rasiah, Kris, Frydenberg, Mark, Roberts, Matthew J., Malouf, David, Wong, David, Shnier, Ron, Delprado, Warick, Emmett, Louise, Stricker, Phillip D. and Thompson, James (2023). 68Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study. Translational Andrology and Urology, 12 (10), 1598-1606. doi: 10.21037/tau-22-708
2023
Journal Article
Prostate volume analysis in image registration for prostate cancer care: a verification study
Bugeja, Jessica M., Mehawed, Georges, Roberts, Matthew J., Rukin, Nicholas, Dowling, Jason and Murray, Rebecca (2023). Prostate volume analysis in image registration for prostate cancer care: a verification study. Physical and Engineering Sciences in Medicine, 46 (4), 1-12. doi: 10.1007/s13246-023-01342-4
2023
Journal Article
High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints
Raghubar, Arti M., Matigian, Nicholas A., Crawford, Joanna, Francis, Leo, Ellis, Robert, Healy, Helen G., Kassianos, Andrew J., Ng, Monica S. Y., Roberts, Matthew J., Wood, Simon and Mallett, Andrew J. (2023). High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific immune checkpoints. npj Precision Oncology, 7 (1) 88, 1-9. doi: 10.1038/s41698-023-00441-5
2023
Journal Article
DIPPER trial protocol: A multi‐centre, randomised trial of salvage radiotherapy versus surveillance for biochemical recurrence after radical prostatectomy (ANZUP 2002)
Roberts, Matthew J., Conduit, Ciara, Davis, Ian D., Effeney, Rachel M., Williams, Scott, Martin, Jarad M., Hofman, Michael S., Hruby, George, Eapen, Renu, Gianacas, Chris, Papa, Nathan, Lourenço, Richard De Abreu, Dhillon, Haryana M, Allen, Ray, Fontela, Antoinette, Kaur, Baldeep, Emmett, Louise and The Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) (2023). DIPPER trial protocol: A multi‐centre, randomised trial of salvage radiotherapy versus surveillance for biochemical recurrence after radical prostatectomy (ANZUP 2002). BJU International, 133 (S3), 39-47. doi: 10.1111/bju.16158
2023
Journal Article
Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management
Pathmanathan, Shivanshan, Tariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dhiantravan, Nattakorn, Esler, Rachel, Dunglison, Nigel, Navaratnam, Anojan, Yaxley, John, Thomas, Paul, Pattison, David A., Goh, Jeffrey C., Gan, Chun Loo and Roberts, Matthew J. (2023). Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management. European Journal of Nuclear Medicine and Molecular Imaging, 51 (1), 295-303. doi: 10.1007/s00259-023-06380-4
2023
Journal Article
Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework
Patel, Nishal, Mehawed, Georges, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John, Chung, Eric, Tse, Vincent and Roberts, Matthew J. (2023). Uro-symphyseal fistula: a systematic review to inform a contemporary, evidence-based management framework. Urology, 178, 1-8. doi: 10.1016/j.urology.2023.05.002
2023
Journal Article
A novel risk calculator incorporating clinical parameters, multiparametric magnetic resonance imaging, and prostate-specific membrane antigen positron emission tomography for prostate cancer risk stratification before transperineal prostate biopsy
Kelly, Brian D., Ptasznik, Gideon, Roberts, Matthew J., Doan, Paul, Stricker, Phillip, Thompson, James, Buteau, James, Chen, Kenneth, Alghazo, Omar, O'Brien, Jonathan S., Hofman, Michael S., Frydenberg, Mark, Lawrentschuk, Nathan, Lundon, Dara, Murphy, Declan G., Emmett, Louise and Moon, Daniel (2023). A novel risk calculator incorporating clinical parameters, multiparametric magnetic resonance imaging, and prostate-specific membrane antigen positron emission tomography for prostate cancer risk stratification before transperineal prostate biopsy. European Urology Open Science, 53, 90-97. doi: 10.1016/j.euros.2023.05.002
2023
Conference Publication
Lu-PSMA Therapy - Practical considerations for urologists
Collin, Harry, Keogh, Kandice and Roberts, Matthew (2023). Lu-PSMA Therapy - Practical considerations for urologists. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley.
2023
Conference Publication
PRIMARY2 Trial Protocol: Phase III, multicentre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer
Buteau, James, Moon, Daniel, Fahey, Michael, Roberts, Matthew, Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, Kasivisvanathan, Veeru, Stricker, Phillip, O'Brien, Jonathan, Counter, William, Sharma, Gaurav, Agrawal, Shikha, Ho, Bao, Dilulio, Juliana, Lindeman, William, De Abreu, Lourenco Richard, Dhillon, Haryana M., Hofman, Michael S. and Emmett, Louise (2023). PRIMARY2 Trial Protocol: Phase III, multicentre, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 PET/CT in men with negative/equivocal MRI in the diagnosis of clinically significant prostate cancer. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley.
2023
Conference Publication
Can artificial intelligence devise surveillance regimens for testicular cancer?
Collin, Harry, Keogh, Kandice and Roberts, Matthew (2023). Can artificial intelligence devise surveillance regimens for testicular cancer?. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley.
2023
Conference Publication
Dr Bot - Does AI provide quality information to prostate cancer patients?
Collin, Harry, Keogh, Kandice and Roberts, Matthew (2023). Dr Bot - Does AI provide quality information to prostate cancer patients?. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley.
2023
Journal Article
Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand
O' Callaghan, Michael E., Roberts, Matthew, Grummet, Jeremy, Mark, Stephen, Gilbourd, Daniel, Frydenberg, Mark, Millar, Jeremy and Papa, Nathan (2023). Trends and variation in prostate cancer diagnosis via transperineal biopsy in Australia and New Zealand. Urologic Oncology: Seminars and Original Investigations, 41 (7), 324.e13-324.e20. doi: 10.1016/j.urolonc.2023.05.011
2023
Conference Publication
Initial diagnostic accuracy of FDG-PET compared to PSMA-PET for newly diagnosed high risk prostate cancer prior to treatment: FIND Trial
Roberts, Matthew, Roberts, Natasha, Harley, Simon, Cullen, Karla, Pelecanos, Anita, Vela, Ian, Yaxley, John, Kuchel, Anna, Dhiantravan, Nattakorn, Thomas, Paul and Pattison, David (2023). Initial diagnostic accuracy of FDG-PET compared to PSMA-PET for newly diagnosed high risk prostate cancer prior to treatment: FIND Trial. 2023 ANZUP Annual Scientific Meeting, Bouncing Back, Melbourne, VIC, Australia, 9-11 July 2023. Hoboken, NJ, United States: Wiley.
2023
Journal Article
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?
Keogh, Kandice, Collin, Harry, Dowling, Caroline and Roberts, Matthew J. (2023). Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?. BJU International, 133 (S3), 6-7. doi: 10.1111/bju.16096
Funding
Current funding
Supervision
Availability
- Dr Matthew Roberts is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Roles of image fusion and 3D technology in urology: exploration and clinical integration for personalised devices
Associate Advisor
Other advisors: Professor Kristofer Thurecht, Dr Nick Rukin
Media
Enquiries
For media enquiries about Dr Matthew Roberts's areas of expertise, story ideas and help finding experts, contact our Media team: